O
AKUS

OrbiMed’s Akouos Inc AKUS Stock Holding History

OrbiMed’s Portfolio AKUS Stock Details AKUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-315,000
Closed -$6.25M – 184
2020
Q4 		$6.25M Hold
315,000
– – 0.05% 137
2020
Q3 		$7.2M Hold
315,000
– – 0.09% 119
2020
Q2 		$7.09M Buy
+315,000
New +$7.02M 0.1% 111

Other funds holding AKUS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

OrbiMed's AKUS Position: Q1 2021 in Review

OrbiMed sold out of Akouos Inc (AKUS) in Q1 2021, closing a stake of 315,000 shares — an estimated $6.25M sold.

OrbiMed first reported a position in AKUS in Q2 2020 and held it in 3 quarters. The position peaked at $7.2M in Q3 2020. 77 funds tracked by Wall St. Rank hold AKUS as of Q1 2021.

  • OrbiMed reported no remaining Akouos Inc position as of Q1 2021 after selling out during the quarter.
  • OrbiMed sold 315,000 Akouos Inc shares in Q1 2021, an estimated $6.25M.
  • OrbiMed first reported a position in Akouos Inc in Q2 2020 and held it in 3 quarters.
  • OrbiMed's Akouos Inc position peaked at $7.2M in Q3 2020.
  • 77 funds tracked by Wall St. Rank held Akouos Inc as of Q1 2021.

Based on OrbiMed's 13F filing for Q1 2021, filed 17 May 2021.